Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Report 2024

This Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market size has grown strongly in recent years. It will grow from $1.72 billion in 2023 to $1.83 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The rise observed in the past is linked to a higher incidence of cardiovascular diseases, an aging demographic, a shift towards minimally invasive procedures, escalating obesity rates, and advancements in healthcare infrastructure.

The percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth in the future is driven by a focus on preventive healthcare, patient desire for shorter hospital stays, supportive reimbursement policies, growing use of drug-eluting balloons, and advancements in diagnostic techniques. Key trends expected include technological innovations, expansion into new markets, greater patient awareness, personalized catheters, and integration with imaging technologies.

The rising prevalence of cardiovascular diseases is anticipated to drive the growth of the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market. Cardiovascular diseases are increasing due to lifestyle factors such as poor diet, lack of exercise, high stress levels, and an aging global population. PTCA dilation catheters are utilized to open narrowed or blocked coronary arteries, thereby restoring blood flow to the heart. For example, the American Heart Association, a US-based organization that supports cardiovascular research, reported in June 2024 that 45 million adults in the USA are projected to have some form of cardiovascular disease by 2050, compared to 28 million in 2020. This includes significant increases in hypertension, which is expected to rise from 51.2% to 61%, and obesity, projected to grow from 43.1% to 60.6%. Thus, the increasing prevalence of cardiovascular diseases is boosting the demand for PTCA dilation catheters.

Key companies in the PTCA dilation catheters market are developing advanced products, such as dilation catheters with twin-wall technology, to improve balloon strength and artery dilation effectiveness. Twin-wall technology involves a unique construction with two concentric layers, enhancing the catheter's strength, flexibility, and durability for precise and controlled dilation procedures. For instance, in February 2023, SIS Medical AG, a Switzerland-based medical device company, introduced the OPN NC PTCA dilation catheter with Twin-Wall technology in the USA. This catheter offers high-pressure resistance with a rated burst pressure of 35 atm and low compliance, making it ideal for post-dilatation of under-expanded stents. Its design ensures exceptional pressure resistance and very low compliance, allowing effective treatment of challenging coronary lesions without the risk of over-dilation.

In June 2024, Boston Scientific Corporation, a U.S.-based manufacturer of medical devices, announced its acquisition of Silk Road Medical Inc. for an undisclosed amount. This acquisition enhances Boston Scientific's capabilities in the vascular and endovascular markets, specifically in the treatment of carotid artery disease. Silk Road Medical Inc. is also a U.S.-based company that specializes in manufacturing medical equipment.

Major companies operating in the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Biosensors International Group Ltd., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Hexacath, Translumina Therapeutics LLP, Eurocor Tech GmbH, GADA S.p.A., Invamed Group.

North America was the largest region in the percutaneous transluminal coronary angioplasty dilation catheters market in 2023. The regions covered in the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Percutaneous transluminal coronary angioplasty (PTCA) dilation catheters are medical tools used to clear narrowed or blocked coronary arteries. This procedure involves inserting a catheter with a small balloon at its end into the artery, then inflating the balloon to enlarge the artery and enhance blood flow. This minimally invasive approach helps restore adequate blood circulation to the heart.

There are two primary types of PTCA dilation catheters semi-compliant and non-compliant. Semi-compliant PTCA catheters are engineered to expand under pressure while maintaining some flexibility. This feature allows them to conform to the artery's shape, providing effective dilation with a reduced risk of causing vessel damage. These catheters are constructed from various materials, such as polyurethane and nylon, and are used in settings such as hospitals and medical research facilities.

The percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market research report is one of a series of new reports that provides percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market statistics, including percutaneous transluminal coronary angioplasty (PTCA) dilation catheters industry global market size, regional shares, competitors with a percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market share, detailed percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market segments, market trends and opportunities, and any further data you may need to thrive in the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters industry. This percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market consists of sales of balloon catheters, drug-eluting balloon catheters, scoring balloon catheters, and cutting balloon catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.